Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA).

Mease, Philip J; Gladman, Dafna D; Samad, Ahmed S; Coates, Laura C; Liu, Lyrica X H; Aras, Girish A; Collier, David H; Chung, James B

Mease, Philip J; Gladman, Dafna D; Samad, Ahmed S; Coates, Laura C; Liu, Lyrica X H; Aras, Girish A; Collier, David H; Chung, James B.

Afiliación

Mease PJ; Rheumatology Clinical Research Division, Swedish Medical Center and Division of Rheumatology, University of Washington, Seattle, Washington, USA.
Gladman DD; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Samad AS; US Medical Organization, Amgen Inc., Thousand Oaks, CA, USA.
Coates LC; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Liu LXH; Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA, USA.
Aras GA; Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA, USA.
Collier DH; US Medical Organization, Amgen Inc., Thousand Oaks, CA, USA.
Chung JB; US Medical Organization, Amgen Inc., Thousand Oaks, CA, USA.

RMD Open ; 4(1): e000606, 2018.

Article en En | MEDLINE | ID: mdl-29531787

Palabras clave

anti-TNF; methotrexate; psoriatic arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: RMD Open Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google